KalVista Pharmaceuticals, Inc.: Positive Opinion from SVB Securities LLC



Marketzone with MT Newswires 2022

All the news about KALVISTA PHARMACEUTICALS, INC.

Analyst Recommendations for KALVISTA PHARMACEUTICALS, INC.

CA 2023 –
–
–
2023 net result -105M
–
-105M
trso. net 2023 163M
–
164M
PER 2023-1.42x
2023 return–
Capitalization 144M
144M
144M
VE / CA 2023–
VE / CA 20240.23x
Number of employees105
Floating97.2%

Chart KALVISTA PHARMACEUTICALS, INC.


Hard :

Period:




KalVista Pharmaceuticals, Inc. : KalVista Pharmaceuticals, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis KALVISTA PHARMACEUTICALS, INC.

Short termMiddle termLong term
TrendsBearishBearishBearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts6
Last Closing Price$5.85
Average price target$27.17
Deviation / Average Target364%

Officers and Directors




Source link -88